U.S. Capital Wealth Advisors’s bluebird bio BLUE Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,360	Closed	-$337K	–	719
2021 Q3	$337K	Buy	+1,360	New	+$389K	0.01%	590

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

U.S. Capital Wealth Advisors's BLUE Position: Q4 2021 in Review

U.S. Capital Wealth Advisors sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 1,360 shares — an estimated $337K sold.

U.S. Capital Wealth Advisors first reported a position in BLUE in Q3 2021 and held it in 1 quarter. The position peaked at $337K in Q3 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

U.S. Capital Wealth Advisors reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 1,360 bluebird bio shares in Q4 2021, an estimated $337K.
U.S. Capital Wealth Advisors first reported a position in bluebird bio in Q3 2021 and held it in 1 quarter.
U.S. Capital Wealth Advisors's bluebird bio position peaked at $337K in Q3 2021.
172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on U.S. Capital Wealth Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.